C4 Therapeutics stock price
C4 테라퓨틱스NASDAQ:CCCC · Nasdaq · HealthcareToday's signals · RSI rebound
Signal details →C4 Therapeutics last closed at $2.95 (-6.05%) on 2026-10-02. Signals today: RSI rebound. Listed on Nasdaq. Trailing 12 months PER is -3.8×. Its overall grade ranks 133 of 739 stocks in Healthcare.
About this company
C4 Therapeutics last closed at $2.95 (-6.05%) on 2026-10-02. Signals today: RSI rebound. Listed on Nasdaq.
Details →Reported results
Position in sector
Healthcare · Overall A · 133/739
Valuation grade A-
Related stocks
- AmgenCustomer
C4 Therapeutics의 분해제(degrader) 플랫폼 기반 후보물질 협업 가능성이 큰 대형 바이오 고객
- Bristol Myers SquibbCustomer
표적 단백질 분해제 분야에서 C4의 파트너/고객으로 거론되는 글로벌 제약사
- BiogenCustomer
C4 Therapeutics와 협력 이력이 있는 신경과학 중심 대형 바이오 고객
About C4 Therapeutics
- What technical signals does C4 Therapeutics (CCCC) have?
- C4 Therapeutics current technical signals: RSI rebound.
- Is C4 Therapeutics a cup-and-handle pattern?
- No. C4 Therapeutics has no valid Cup signal right now.
- What published figures are available for C4 Therapeutics?
- Market cap: $285.9M. Trailing 12 months PER: -3.8×. Latest quarter PBR: 1.56×. Dividend yield: 0.00%.
Like these rules? Backtest them.
Run this signal on this ticker in the free backtest builder — same window, no install.
Backtest this rule ↗Major stocks in the same sector
2026-10-04 dataset
Turn what you saw on this name into a strategy
Ask Q about C4 Therapeutics, or open the plan table on the main site.
From the names you found, through to a scheduled run
Set the conditions and they run at the scheduled time (live orders are not open yet).